Algeta schedules first quarter 2013 results presentation, webcast and conference call

Algeta schedules first quarter 2013 results presentation, webcast and 
conference call 
OSLO, NORWAY -- (Marketwired) -- 05/07/13 --  Algeta ASA (OSE:
ALGETA), a company focused on the
development of novel targeted
cancer therapeutics, will announce its first quarter 2013 results on
Wednesday, 15 May 2013. A presentation by Algeta's senior management
team to investors, analysts and the press will take place in
Oslo at
10:00 CET. 
The  presentation  will  also  be  webcast  live  and  can  be 
accessed through
www.algeta.com where questions can also be submitted
during the presentation. 
The presentation will take place at 10:00 CET at: 
Shippingklubben 
Haakon VIIs gate 1
 0161 Oslo
 Norway. 
Algeta's  senior management will  also host an  international
conference call at 14:30 CET/08:30 Eastern Time (US) (details below). 
To  participate in the conference call, please dial the appropriate
number below
five minutes prior to the call: 
US: +1 877 423 0830
 UK: +44 20 7153 9154
 Norway: +47 21 06 61 13 
Sweden: +46 8-506 443 86
 Denmark: +45 32 71 42 62
 Switzerland: +41
44 580 65 22 
Participant pin code: 281404# 
To access the replay, please dial: 
US: +1 877 679 2989
 UK: +44 20 3364 5196
 Norway: +47 23 50 02 03 
Sweden: +46 8-505 564 73 
Conference reference: 346423# 
A   replay   version   of   the  conference  call  will  also  be
available  at www.algeta.com. 
The  results report and the presentation  will be available at
www.algeta.com in the Investors section from 07:00 CET. 
### 
About Algeta 
Algeta is a company focused on developing novel targeted therapies
for patients
with cancer based on its alpha-pharmaceutical platform.
The Company is headquartered in Oslo, Norway, and has a US
subsidiary, Algeta US, LLC, based in Cambridge, MA performing
commercial marketing operations in the US. Algeta is
listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information
please
visit www.algeta.com. 
Press release: http://hugin.info/134655/R/1699187/560422.pdf 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
that: 
(i) the releases contained herein are protected by copyright and    
other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and     
originality of the information contained therein. 
Source: Algeta ASA via Thomson Reuters ONE 
[HUG#1699187] 
For further information, please contact:
Mike Booth / Renate Birkeli
Communications & Corporate Affairs
+47 23 00 67 32
ir@algeta.com 
Media enquiries:
Mark Swallow
Citigate Dewe Rogerson
+44 207 638 9571
mark.swallow@citigatedr.co.uk 
Knut Ekern
Gambit Hill & Knowlton
+47 22 04 82 00
knut.ekern@hkstrategies.com 
Kari Watson
MacDougall Biomedical Communications
+1 781 235 3060
kwatson@macbiocom.com 
US investor enquiries:
Tricia Swanson
The Trout Group
+1 646 378 2953
tswanson@troutgroup.com